Brief: BioInvent Q3 Sales SEK 3.3 Million
29/10/2025 07:00
Oct 29 (Reuters) - BioInvent Q3 adjusted EPS SEK -1.96. Q3 adjusted free cash flow SEK -104 million Q3 net income SEK -129.2 million
BINV — BioInvent International AB News Story
0.000.00%
Last trade - 00:00- SEK1.59bn
- SEK1.14bn
- SEK226.50m